Drowsiness

N

110

946

1421

1164

1164

ROR

4.16

2.56

2.98

2.54

2.99

95% CI

(3.43, 5.02)

(2.40, 2.73)

(2.82, 3.14)

(2.41, 2.67)

(2.82, 3.18)

Irritability

N

112

894

2188

1277

966

ROR

8.27

4.78

2.98

4.33

4.89

95% CI

(6.84, 9.99)

(4.47, 5.11)

(2.82, 3.14)

(4.09, 4.58)

(4.58, 5.22)

Tremor

N

124

1112

2453

1920

1283

ROR

5.02

3.24

5.17

3.57

3.55

95% CI

(4.19, 6.00)

(3.05, 3.44)

(5.48, 5.95)

(3.41, 3.74)

(3.35, 3.75)

Amnesia

N

40

441

756

718

444

ROR

3.31

2.66

3.54

2.77

2.51

95% CI

(2.43, 4.53)

(2.42, 2.92)

(3.29, 3.81)

(2.57, 2.98)

(2.29, 2.75)

5-HT syndrome

N

95

692

662

956

706

ROR

37.00

21.10

14.31

19.25

20.44

95% CI

(30.18, 45.57)

(19.56, 22.94)

(13.17, 1.56)

(17.96, 20.63)

(18.89, 22.12)

Dyskinesia

N

27

307

415

497

299

ROR

4.27

3.55

3.70

3.66

3.26

95% CI

(2.92, 6.24)

(3.17, 3.98)

(3.36, 4.08)

(3.34, 4.00)

(2.91, 3.66)

Weight increased

N

87

1237

2019

1749

950

ROR

2.92

3.04

3.86

2.70

2.17

95% CI

(2.36, 3.61)

(2.87, 3.21)

(3.69, 4.04)

(2.58, 2.84)

(4.58, 5.22)

Cholesterolemia

N

25

455

434

749

370

ROR

2.90

3.89

2.83

4.08

2.96

95% CI

(1.95, 4.30)

(3.54, 4.27)

(2.57, 3.11)

(3.79, 4.39)

(2.67, 3.28)

Blood triglycerides increased

N

22

243

434

314

204

ROR

5.69

4.62

2.83

3.77

3.64

95% CI

(3.74, 8.65)

(4.07, 5.25)

(2.57, 3.11)

(3.37, 4.23)

(3.17, 4.19)

Neutrophilia

N

13

71

91

108

64

ROR

9.06

3.61

3.56

3.48

3.06

95% CI

(5.25, 15.63)

(2.85, 4.57)

(2.89, 4.39)

(2.88, 4.22)

(2.39, 3.92)